<bill session="110" type="s" number="2311" updated="2013-07-19T22:41:00-04:00">
  <state datetime="2007-11-06">REFERRED</state>
  <status>
    <introduced datetime="2007-11-06"/>
  </status>
  <introduced datetime="2007-11-06"/>
  <titles>
    <title as="introduced" type="short">Non-Prescription Drug Modernization Act of 2007</title>
    <title as="introduced" type="official">A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes.</title>
  </titles>
  <sponsor id="300059"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2007-11-06">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral, In Committee"/>
  </committees>
  <relatedbills>
    <bill relation="identical" session="110" type="h" number="4083"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer education"/>
    <term name="Deceptive advertising"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug adulteration"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government operations and politics"/>
    <term name="Labeling"/>
    <term name="Law"/>
  </subjects>
  <amendments/>
  <summary>11/6/2007--Introduced.
Non-Prescription Drug Modernization Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to authorize: (1) the amendment or repeal of an over-the-counter drug monograph without notice and public procedure if there is a finding by the Secretary of Health and Human Services that a category of drugs or a specific drug is associated with a significant risk or that such drugs lack evidence of effectiveness; and (2) the Food and Drug Administration (FDA) to regulate over-the-counter drug advertisements.Directs the Commissioner of Food and Drugs to identify over-the-counter drug monographs that may require amendment or repeal and to report the findings to Congress.</summary>
</bill>
